Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.3B | 5.0B | 4.9B |
Cost of revenue | 1.8B | 2.1B | 1.9B | 1.8B |
Gross profit | 3.2B | 3.2B | 3.2B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.5B | 1.5B | 1.5B | 1.5B |
Other operating expenses | 7M | -22M | 6M | 3M |
Operating income | 706M | 731M | 725M | 605M |
Non operating interest income | ||||
Income | 5M | 5M | 10M | 11M |
Expense | 342M | 382M | 347M | 345M |
Other income expense | 39M | 84M | -79M | 29M |
Pretax income | 408M | 438M | 309M | 300M |
Tax provision | 107M | 118M | 52M | 79M |
Net income | 301M | 320M | 257M | 221M |
Basic EPS | 0.2 | — | 0.2 | 0.2 |
Diluted EPS | 0.2 | — | 0.2 | 0.2 |
Basic average shares | 2.1B | — | 2.1B | 2.1B |
Diluted average shares | 2.1B | — | 2.1B | 2.1B |
EBITDA | 1.7B | 1.9B | 1.7B | 1.6B |
Net income from continuing op. | 301M | 320M | 257M | 221M |
Minority interests | 20M | 38M | 23M | 7M |
Preferred stock dividends | — | — | — | — |